Pretreatment with an Aerosol Foam Containing Calcipotriene and Betamethasone Strongly Improves the Efficacy of Narrow-Band UVB Phototherapy

[1]  L. Puig,et al.  Safety of calcipotriene and betamethasone dipropionate foam for the treatment of psoriasis , 2020, Expert opinion on drug safety.

[2]  P. Wolf,et al.  How It Works: The Immunology Underlying Phototherapy. , 2020, Dermatologic clinics.

[3]  S. Segaert,et al.  Rapid onset of action of calcipotriol/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[4]  M. Lebwohl,et al.  Itch relief in patients with psoriasis: effectiveness of calcipotriol plus betamethasone dipropionate foam , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[5]  P. Calzavara-Pinton,et al.  Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted indirect comparison , 2019, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  J. Bagel,et al.  A Prospective, Open-Label Study Evaluating Adjunctive Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam in Psoriasis Patients With Inadequate Response to Biologic Therapy. , 2018, Journal of drugs in dermatology : JDD.

[7]  A. Ormerod,et al.  Differential effects of phototherapy, adalimumab and betamethasone–calcipotriol on effector and regulatory T cells in psoriasis , 2018, The British journal of dermatology.

[8]  J. Bagel,et al.  Combining Topical Psoriasis Treatment to Enhance Systemic and Phototherapy: A Review of the Literature. , 2017, Journal of drugs in dermatology : JDD.

[9]  P. Gisondi,et al.  European S3‐Guideline on the systemic treatment of psoriasis vulgaris – Update Apremilast and Secukinumab – EDF in cooperation with EADV and IPC , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  K. Papp,et al.  Patients with psoriasis have different preferences for topical therapy, highlighting the importance of individualized treatment approaches: randomized phase IIIb PSO‐INSIGHTFUL study , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  K. Andersen,et al.  Worldwide utilization of topical remedies in treatment of psoriasis: a systematic review , 2017, The Journal of dermatological treatment.

[12]  K. Tasanen,et al.  Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis. , 2017, Acta dermato-venereologica.

[13]  M. Lebwohl,et al.  Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study , 2017, American Journal of Clinical Dermatology.

[14]  C. Griffiths,et al.  Calcipotriol plus betamethasone dipropionate aerosol foam provides superior efficacy vs. gel in patients with psoriasis vulgaris: randomized, controlled PSO‐ABLE study , 2016, Journal of the European Academy of Dermatology and Venereology : JEADV.

[15]  C. Leonardi,et al.  The Aerosol Foam Formulation of the Fixed Combination Calcipotriene Plus Betamethasone Dipropionate Improves the Health-Related Quality of Life in Patients With Psoriasis Vulgaris: Results from the Randomized PSO-FAST Study. , 2016, Journal of drugs in dermatology : JDD.

[16]  M. Lebwohl,et al.  Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 Study. , 2016, The Journal of clinical and aesthetic dermatology.

[17]  C. Leonardi,et al.  Efficacy and Safety of Calcipotriene Plus Betamethasone Dipropionate Aerosol Foam in Patients With Psoriasis Vulgaris--a Randomized Phase III Study (PSO-FAST). , 2015, Journal of drugs in dermatology : JDD.

[18]  P. Gisondi,et al.  European S3‐Guidelines on the systemic treatment of psoriasis vulgaris – Update 2015 – Short version – EDF in cooperation with EADV and IPC , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  J. Koo,et al.  Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris – A randomized phase II study , 2015, The Journal of dermatological treatment.

[20]  H. Koenen,et al.  Balance of Treg versus T‐effector cells during systemic treatment with adalimumab and topical treatment with calcipotriol–betamethasone dipropionate ointment , 2015, Experimental dermatology.

[21]  N. Akdeniz,et al.  Comparison of efficacy of narrow band UVB therapies with UVB alone, in combination with calcipotriol, and with betamethasoneand calcipotriol in vitiligo , 2014, The Journal of dermatological treatment.

[22]  S. Segaert,et al.  The biological rationale for use of vitamin d analogs in combination with corticosteroids for the topical treatment of plaque psoriasis. , 2013, Journal of drugs in dermatology : JDD.

[23]  H. Wulf,et al.  Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice , 2010, Experimental dermatology.

[24]  B. Elewski,et al.  Optimizing topical therapies for treating psoriasis: a consensus conference. , 2010, Cutis.

[25]  J. Saurat,et al.  A phase IIIb, multicentre, randomized, double‐blind, vehicle‐controlled study of the efficacy and safety of adalimumab with and without calcipotriol/betamethasone topical treatment in patients with moderate to severe psoriasis: the BELIEVE study , 2010, The British journal of dermatology.

[26]  Corrie Rogers.  Calcipotriol (Dovobet) ointment in combination with UVB therapy for psoriasis treatment. , 2006, Dermatology nursing.

[27]  Dawe,et al.  Narrowband ultraviolet B (TL‐01) phototherapy for psoriasis: which incremental regimen? , 1998, The British journal of dermatology.

[28]  L. Misery,et al.  Efficacy of Systemic Treatments of Psoriasis on Pruritus: A Systemic Literature Review and Meta-Analysis. , 2018, The Journal of investigative dermatology.

[29]  P. Calzavara-Pinton.  Efficacy and safety of stand-up irradiation cubicles with UVA metal-halide lamps (and a new filter) or UVA fluorescent lamps for photochemotherapy of psoriasis. , 1997, Dermatology.